NASDAQ:FGEN
FibroGen Stock News
$1.20
-0.0400 (-3.23%)
At Close: May 17, 2024
RADNOR, Pa., June 1, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, Inc. (NASD
FGEN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving FibroGen, Inc.
03:31pm, Tuesday, 01'st Jun 2021
New York, New York--(Newsfile Corp. - June 1, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("
New York, New York--(Newsfile Corp. - June 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib
NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of its office
New York, New York--(Newsfile Corp. - May 31, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging th
New York, New York--(Newsfile Corp. - May 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib
Fibrogen Investor Alert
08:09am, Sunday, 30'th May 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile C
New York, New York--(Newsfile Corp. - May 29, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain
NEW YORK, May 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of FibroGen, Inc. (NASDAQ: FGEN) between October 18, 2017 and April
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of FibroGen, Inc. of Deadline in Securities Fraud Class Action Lawsuit
11:07am, Saturday, 29'th May 2021
Radnor, Pennsylvania--(Newsfile Corp. - May 29, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGe
FibroGen Update
08:39am, Saturday, 29'th May 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile C
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN)
01:00pm, Friday, 28'th May 2021
LOS ANGELES, May 28, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on
New Orleans, Louisiana--(Newsfile Corp. - May 28, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un
FibroGen Class Action Reminder
07:31pm, Thursday, 27'th May 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile C
FibroGen to Present at Upcoming Investor Conferences
07:00am, Thursday, 27'th May 2021
SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following virtua